How I Made $5000 in the Stock Market

These Stocks Moved the Most Today: Tesla, IBM, D-Wave Quantum, Dow Inc., Molina Healthcare, Las Vegas Sands, Southwest, and More

Oct 23, 2025 05:36:00 -0400 by Joe Woelfel | #Technology

Traders working at the New York Stock Exchange (NYSE)

Key Points

Stocks traded higher Thursday, with the Nasdaq Composite rebounding as Wall Street bought the dip in riskier stocks.

These stocks made notable moves Thursday:

Tesla pared earlier losses to rise 2.3%. The electric-vehicle maker reported a 37% decline in third-quarter net income. Adjusted earnings in the period of 50 cents a share missed analysts’ estimates of 56 cents, even as total revenue jumped 12% to $28.1 billion, higher than Wall Street expectations of $26.5 billion. Automotive revenue of $21.2 billion topped estimates of $19.6 billion, boosted by a rush by consumers to buy EVs before the expiration of U.S. federal tax credits. Tesla’s free cash flow in the quarter was $3.99 billion, the highest quarterly total in the company’s history.

International Business Machines swung to a profit in the third quarter as revenue of $16.33 billion rose 9% from a year earlier and beat Wall Steet estimates of $16.09 billion. Adjusted earnings in the quarter of $2.65 a share topped analysts’ forecasts of $2.45. For the full year, IBM forecasts more than 5% revenue growth in constant currency and expects to generate about $14 billion in free cash flow. Shares, however, fell 0.9%, as the stock’s rally this year had set a high bar.

IonQ rose 7.1%, Rigetti Computing gained 9.8%, and D-Wave Quantum jumped 14% after The Wall Street Journal reported the Commerce Department was considering taking equity stakes in the companies in exchange for federal funding. The Commerce Department denied the report, telling Barron’s it isn’t currently negotiating equity stakes with quantum computing companies.

Honeywell International rose 6.8% after the industrial conglomerate reported better-than-expected third-quarter earnings. The company posted earnings $2.82 a share on sales of $10.4 billion. Wall Street was expecting earnings of $2.57 on sales of $10.1 billion.

Dow Inc. jumped 13% as the commodity chemicals producer reported an adjusted loss in the third quarter of 19 cents a share on net sales of $10 billion versus Wall Street expectations that called for a loss of 31 cents on sales of $10.2 billion. Operating profit of $180 million fell from $461 million a year earlier. CEO Jim Fitterling noted “continued pressure across our industry.” He added that Dow remains confident it was “in a strong position to navigate this environment.”

American Airlines climbed 5.6% after the carrier reported a narrower-than-expected third-quarter loss and beat analysts’ revenue expectations. The airline also signaled a strong end to 2025 as it hiked full-year guidance and forecast a fourth-quarter profit above estimates.

Southwest Airlines reported a surprise third-quarter adjusted profit of 11 cents a share, better than analysts’ calls for a loss of 4 cents, as the discount carrier said “results are showing” from its strategy shift. Southwest reported record third-quarter revenue of $6.95 billion. The airline said it expects “meaningful margin expansion in the fourth quarter.” However, the results didn’t impress Wall Street, and shares declined 6.3%.

Third-quarter revenue at T-Mobile rose 8.9% from a year earlier to $21.96 billion, beating the $21.91 billion analysts had expected. The telecommunications company added a record 2.3 million postpaid subscribers over the quarter. The stock, which has been tamped down this year due to concerns about an economic slowdown, declined 3.3%.

Moderna fell 2.2% after saying it would stop development of a vaccine designed to prevent birth defects caused by cytomegalovirus, or CMV, once among its most-watched experimental programs. Moderna had hoped its shot would be at least 49% effective at preventing CMV infections. But top-line data from a Phase 3 trial in 7,500 women found the shot was only between 6% and 23% effective.

West Pharmaceutical Services gained 11% after the company raised its forecast for the year. West Pharmaceutical expects adjusted earnings of $7.06 to $7.11 a share on sales of $3.06 billion to $3.07 billion. Previous guidance called for adjusted earnings of $6.65 to $6.85 a share on sales of $3.04 billion to $3.06 billion.

Las Vegas Sands jumped 12% after the casino company reported third-quarter adjusted earnings of 78 cents a share, beating analysts’ estimates of 62 cents, as revenue jumped 24% to $3.33 billion. Casino revenue in the quarter rose to $2.51 billion from $1.94 billion a year earlier.

Molina Healthcare tumbled 17% after it again cut its full-year guidance and reported lower third-quarter earnings because of underperformance in the healthcare-services provider’s marketplace business. Net income of $79 million, or $1.51 a share, declined from $326 million, or $5.65 a year earlier. Adjusted earnings of $1.84 a share missed forecasts of $3.90. Peer insurer Centene dropped 4.6% while healthcare giant UnitedHealth traded down 0.3%.

Medpace Holdings rose 9.1% after the contract research organization posted third-quarter earnings of $3.86 a share on revenue of $659.9 million, significantly higher than a year earlier and better than analysts’ expectations. The company said it sees revenue growth of between 17.6% and 20% for the full year, above a prior forecast of between 14.7% and 19.5%.

Chip-equipment maker Lam Research rose 4.5% as fiscal first-quarter adjusted earnings of $1.26 a share beat analysts’ predictions of $1.22. Revenue rose to $5.32 billion from $4.17 billion a year earlier and topped expectations of $5.22 billion.

Earnings reports were expected later Thursday from Intel, Ford Motor, Newmont and Norfolk Southern.

Write to Joe Woelfel at joseph.woelfel@barrons.com and Mackenzie Tatananni at mackenzie.tatananni@barrons.com